Basit öğe kaydını göster

Prognostic factors in solitary plasmacytoma of the bone: a multicenter Rare Cancer Network study

dc.contributor.authorCastelain, Bernard
dc.contributor.authorOner, FD
dc.contributor.authorLandmann, C
dc.contributor.authorOzsahin, Mahmut
dc.contributor.authorKnobel, David
dc.contributor.authorZouhair, Abderrahim
dc.contributor.authorTsang, Richard W
dc.contributor.authorPoortmans, Philip
dc.contributor.authorBelkacemi, Y
dc.contributor.authorBolla, Michel
dc.date.accessioned2021-03-05T16:01:27Z
dc.date.available2021-03-05T16:01:27Z
dc.identifier.citationKnobel D., Zouhair A., Tsang R. W. , Poortmans P., Belkacemi Y., Bolla M., Oner F., Landmann C., Castelain B., Ozsahin M., "Prognostic factors in solitary plasmacytoma of the bone: a multicenter Rare Cancer Network study", BMC CANCER, cilt.6, 2006
dc.identifier.issn1471-2407
dc.identifier.othervv_1032021
dc.identifier.otherav_bea92dd6-db63-4538-8ce8-4e03c41d8745
dc.identifier.urihttp://hdl.handle.net/20.500.12627/126612
dc.identifier.urihttps://doi.org/10.1186/1471-2407-6-118
dc.description.abstractBackground: Solitary plasmacytoma (SP) of the bone is a rare plasma-cell neoplasm. There are no conclusive data in the literature on the optimal radiation therapy (RT) dose in SP. Therefore, in this large retrospective study, we wanted to assess the outcome, prognostic factors, and the optimal RT dose in patients with SP.
dc.language.isoeng
dc.subjectOnkoloji
dc.subjectDahili Tıp Bilimleri
dc.subjectİç Hastalıkları
dc.subjectSağlık Bilimleri
dc.subjectTıp
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectONKOLOJİ
dc.titlePrognostic factors in solitary plasmacytoma of the bone: a multicenter Rare Cancer Network study
dc.typeMakale
dc.relation.journalBMC CANCER
dc.contributor.department, ,
dc.identifier.volume6
dc.contributor.firstauthorID36060


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster